|Day Low/High||32.35 / 33.50|
|52 Wk Low/High||29.22 / 69.76|
The drugmaker says two studies show that diabetics will prefer inhaled insulin to injections.
The drugmaker has yet to announce a price for the treatment, which it touts as more convenient than injectable insulin.
This year's ADA meeting is set to showcase new and upcoming treatment options.
The drug safety stock just hit a 52-week high but could see another boost soon. Cramer explans why.
Cramer offers his take on Matria, Healthways, Amylin and Nektar Therapeutics in the diabetic sector. Plus, UnitedHealth's CEO gets grilled on options.
Alliances with big pharma are key for boosting smaller companies' profiles.
Misonix soars 57% after the FDA clears its product for removing soft tissue legions in surgeries.
The company expects to resume testing an inhaled insulin device during the first quarter.
The company's earnings Thursday may take a back seat to an update on the cholesterol drug.
Pfizer will pay $1.3 billion to buy out Sanofi-Aventis' share of Exubera.
The FDA tells Pfizer it will need three more months to review the inhaled insulin application.
Cramer says that the retailer is still best of breed despite a profit warning.
Investors will key on diabetes and neuroscience franchises when the company reports Thursday.
Alfred E. Mann's company has a fierce fight in the inhaled insulin market.
Pfizer says an analysis of two clinical trials involved 304 adults with diabetes.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.